Who said I do not like it....I made money off of it. However, valuations being touted on the board are borderline absurd based on what is going on with the company. Which, basically is one man, and a lot of consultants paid with common shares that have yet to prove to us that they are producing any product or bringing in any revenue whatsoever. Hence the reason the stock has not run on biospy news much to the dismay and hopes of many on the board here.